Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02108912 · ClinicalTrials.gov registry record · NA
Metabolic Costs of Walking Post Stroke
A NA study of Acute Stroke, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
- 1
- Study location
NCT02108912: Completed NA study of Acute Stroke, sponsored by University of Texas Southwestern Medical Center.
NCT02108912 is a NA study of Acute Stroke that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 16 participants, below the 6,124-participant average among 10 other Acute Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02108912, a NA study of Acute Stroke, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
This will be a randomized, matched-group study to compare the cardiopulmonary / metabolic benefits for persons post stroke that learn to walk utilizing early treadmill training post-acute stroke to persons post stroke that learn to walk utilizing non-treadmill based gait training during the same time period. Participants (n=30) will be adults who have completed acute rehabilitation following a stroke. Random assignment will be to either the ESTT or traditional gait training protocol during the outpatient rehabilitation phase. 1. Group A: Traditional outpatient therapy (n = 15) 2. Group B: Treadmill training (ESTT) outpatient therapy (n = 15)
Primary Outcome
Exercise tests will be performed with a treadmill with a static/dynamic body weight system. Measurements will be conducted with open circuit spirometry. Heart rate will be continuously monitored by electrocardiogram. Blood pressure will be monitored every 2 minutes. Participants will be allowed a 3-minute warm-up. Following the warm-up, participants will be allowed up to 10 minutes to rest or until they recovery to baseline heart rate, respiration rate and blood pressure.
Conditions Studied
Interventions
- OTHER ESTT
- OTHER Traditional outpatient
Study Locations (1)
Texas
- UT Southwestern School of Health Professions - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2014-03 |
| Est. Completion | 2017-01 |
| Phase | NA |
What the finished NCT02108912 record still lists
NCT02108912 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 6,124-participant average among 10 other Acute Stroke trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Acute Stroke appearing as the primary indexed condition, and to 2 interventions - of which ESTT is the first listed.
NCT02108912 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT02108912 about?
NCT02108912 is a clinical study titled "Metabolic Costs of Walking Post Stroke". This will be a randomized, matched-group study to compare the cardiopulmonary / metabolic benefits for persons post stroke that learn to walk utilizing early treadmill training post-acute stroke to persons post stroke that learn to walk utilizing non-treadmill based gait training during the same tim...
What is the current status of trial NCT02108912?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2014-03. Estimated completion is 2017-01.
What conditions does trial NCT02108912 study?
This clinical trial studies the following conditions: Acute Stroke.
What interventions are being tested in trial NCT02108912?
The interventions under investigation include: ESTT (OTHER), Traditional outpatient (OTHER).
Who is sponsoring clinical trial NCT02108912?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02108912 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02108912's enrollment target sits among peer trials
16 9th of 10 higher than 2 of 10 other Acute Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Acute Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ischemic Conditioning During Air tRansport Save penUmbral Tissue
RECRUITING · NA
-
SEACOAST 1- SEdAtion With COllAteral Support in Endovascular Therapy for Acute Ischemic Stroke
RECRUITING · NA
-
Sensory-Motor Rehabilitation Post Stroke
RECRUITING · NA
-
Non-invasive Brain Stimulation and Occupational Therapy To Enhance Stroke Recovery
COMPLETED · NA
-
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
RECRUITING · Phase 2
-
Stroke Recovery Initiative - Registry for Stroke Research Studies
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia